Abstract 4608: Evaluation of the impact of homozygous MTAP truncations on the clinical activity of MTA-cooperative PRMT5 inhibitors
Kimberly J. Briggs(Io Therapeutics (United States)), Adam Crystal(C4 Therapeutics (United States)), Steven A. Lombardo(Io Therapeutics (United States)), David R. Spigel(Sarah Cannon), Kevin M. Cottrell(Io Therapeutics (United States)), Jennifer Morawiak(Io Therapeutics (United States)), Capucine Baldini(Centre National de la Recherche Scientifique), Ignacio Garrido‐Laguna(University of Utah), Jordi Rodón(The University of Texas MD Anderson Cancer Center), Angela C. Hirbe(Washington University in St. Louis), Ibiayi Dagogo‐Jack(Massachusetts General Hospital), Heather DiBenedetto(Io Therapeutics (United States)), Douglas A. Whittington(Amgen (United States)), Yi Yu(Novartis (United States)), Alexander I. Spira(Virginia Cancer Specialists), Satoshi Yoda(Harvard University), Emiliano Calvo(South Texas Accelerated Research Therapeutics), Andre Mignault(Novartis (United States)), Shangtao Liu(Tango Therapeutics (United States)), Ellen Hooper(Io Therapeutics (United States)), Hongxiang Zhang(Tango Therapeutics (United States)), Binzhang Shen(Tango Therapeutics (United States)), Samuel R. Meier, Hannah Stowe(Massachusetts General Hospital), Minjie Zhang(Xian Yang Central Hospital), Wenhai Zhang(Tango Therapeutics (United States)), Víctor Moreno(Peter MacCallum Cancer Centre), Teng Teng(Wuhan University), Heidi Rego(Io Therapeutics (United States)), Brian Doyon(Tango Therapeutics (United States)), Matthew R. Tonini(Tango Therapeutics (United States)), Candace L. Haddox(Rutgers, The State University of New Jersey)
Cited by 0
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k